ArticlePoultry science2026
Research note: ELISA kit replacement leads to false negatives in ALV eradication-A case study in Chinese yellow-feathered broilers.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The ELISA kit for detecting the p27 antigen of avian leukosis virus (ALV) is a cornerstone reagent in avian leukosis (AL) eradication programs. Its analytical sensitivity is a key determinant of successful eradication. During an AL eradication campaign in a Chinese yellow-feathered broiler breeder flock, an unexpected shift in detection positivity rates occurred following a change in ELISA kit. The new positivity rate was inconsistent with the flock's clinical presentation, raising concerns that the lower sensitivity of the new kit may have resulted in false-negative results. In this study, we selected 200 breeding hens from the affected flock. Aseptically collected anticoagulated blood samples were subjected to virus isolation, and the cell culture supernatants were evaluated using two commercial ELISA kits (designated Kit A and Kit B) and ALV magnetic-particle chemiluminescent antigen detection kit. Kit B, the kit currently in use at the facility, yielded negative results for all 200 samples. In contrast, both Kit A and the magnetic-particle chemiluminescent kit consistently detected 12 positive samples, all of which corresponded to the same individuals. Further sequencing analysis of the env gene from positive plasma samples confirmed avian leukosis virus subgroup K (ALV-K), a strain with low replication capacity. This finding indicates that the insufficient analytical sensitivity of Kit B rendered it ineffective for detecting this particular subgroup. Collectively, this case study underscores the critical importance of pre-evaluating diagnostic kits for ALV eradication-especially when targeting low-replication strains such as ALV-K. For such strains, more sensitive detection platforms should be prioritized to ensure accurate identification and effective control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.